Literature DB >> 10764427

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

C C Park1, M Mitsumori, A Nixon, A Recht, J Connolly, R Gelman, B Silver, S Hetelekidis, A Abner, J R Harris, S J Schnitt.   

Abstract

PURPOSE: To examine the relationship between pathologic margin status and outcome at 8 years after breast-conserving surgery and radiation therapy. PATIENTS AND METHODS: The study population comprised 533 patients with International Union Against Cancer/American Joint Committee on Cancer clinical stage I or II breast cancer who had assessable margins, who received at least 60 Gy to the primary tumor bed, and who had more than 8 years of potential follow-up. Each margin was scored (according to the presence of invasive or in situ disease that touched the inked surgical margin) as one of the following: negative, close, focally positive, or extensively positive. Outcome at 8 years was calculated using crude rates of first site of failure. A polychotomous logistic regression analysis was performed. Median follow-up time was 127 months.
RESULTS: At 8 years, patients with close margins and those with negative margins both had a rate of local recurrence (LR) of 7%. Patients with extensively positive margins had an LR rate of 27%, whereas patients with focally positive margins had an intermediate rate of LR of 14%. In the polychotomous logistic regression model, margin status and the use of systemic therapy were the only two variables that had significant effects on the risk ratio of LR to remaining alive and free of disease. Among the 45 patients with focally positive margins who received systemic therapy, the crude LR rate was 7% at 8 years (95% confidence interval, 1% to 20%).
CONCLUSION: Pathologic margin status and the use of adjuvant systemic therapy are the most important factors associated with LR among patients treated with breast-conserving surgery and radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764427     DOI: 10.1200/JCO.2000.18.8.1668

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  90 in total

Review 1.  Hypofractionated radiation therapy in the treatment of early-stage breast cancer.

Authors:  Gary M Freedman
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 2.  Early breast cancer.

Authors:  Tomoyoshi Suzuki; Masakazu Toi; Shigehira Saji; Kazumi Horiguchi; Tomoyuki Aruga; Eiji Suzuki; Shinichiro Horiguchi; Nobuaki Funata; Katsuyuki Karasawa; Noriko Kamata
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

3.  Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey.

Authors:  Alphonse Taghian; Majid Mohiuddin; Reshma Jagsi; Saveli Goldberg; Elizabeth Ceilley; Simon Powell
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

4.  Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.

Authors:  Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; Emiel J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2005-11-19       Impact factor: 5.315

Review 5.  What is a clear margin in breast conserving cancer surgery?

Authors:  Helen Krontiras; Rachael B Lancaster; Marshall M Urist
Journal:  Curr Treat Options Oncol       Date:  2014-03

6.  Intraoperative Ultrasound in the Treatment of Breast Cancer.

Authors:  H Eggemann; T Ignatov; A Beni; S D Costa; O Ortmann; A Ignatov
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-10       Impact factor: 2.915

7.  Influence of surgical margins on the outcome of breast cancer patients: a retrospective analysis.

Authors:  Sergio Bernardi; Serena Bertozzi; Ambrogio P Londero; Giuliana Gentile; Vito Angione; Roberto Petri
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

8.  A phase I study of intraoperative radiotherapy for early breast cancer in Japan.

Authors:  Masataka Sawaki; Shigenori Sato; Toyone Kikumori; Shunichi Ishihara; Yuichi Aoyama; Yoshiyuki Itoh; Akimasa Nakao; Tsuneo Imai
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

Review 9.  Breast cancer: Actual methods of treatment and future trends.

Authors:  Paweł Murawa; Dawid Murawa; Beata Adamczyk; Karol Połom
Journal:  Rep Pract Oncol Radiother       Date:  2014-01-23

10.  Radioguided occult lesion localisation versus wire-guided lumpectomy in the treatment of non-palpable breast lesions.

Authors:  Tibor Takács; Attila Paszt; Zsolt Simonka; Szabolcs Abrahám; Bernadett Borda; Aurél Ottlakán; Katalin Ormándi; Máté Lázár; András Vörös; Zsuzsanna Kahán; Gyorgy Lazar
Journal:  Pathol Oncol Res       Date:  2012-10-14       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.